Mikrobiol. Z. 2021; 83(4):43-53.
doi: https://doi.org/10.15407/microbiolj83.04.043

Destruction of Biofilms on Silicone Tubes under the Action of a Mixture of
Nocardia vaccinii IMV B-7405 Surfactants with other Biocides

T.P. Pirog1,2, L.V. Kliuchka1, T.A. Shevchuk2, G.O. Iutynska2

1National University of Food Technologies
68 Volodymyrska Str., Kyiv, 01601, Ukraine

2Zabolotny Institute of Microbiology and Virology, NAS of Ukraine
154 Akad. Zabolotny Str., Kyiv, 03143, Ukraine

The formation of pathogenic microorganisms biofilms on the central venous catheter is the cause of catheter-associated infections. An alternative method of combating biofilms is the use of “antibacterial” and “antifungal” locks, which are solutions of antibiotics or antifungal drugs in a mixture with other natural compounds, which can be microbial surface-active substances (surfactants) or essential oils. Aim. To investigate the role of Nocardia vaccinii IMV B-7405 surfactants mixture with other antimicrobial compounds in the destruction of biofilm on silicone tubes. Methods. N. vaccinii IMV B-7405 was grown in medium containing as carbon source purified glycerol and waste from biodiesel production, refined sunflower oil, oil after frying French-fried potatoes, Potato wedges and meat. The surfactants were extracted from supernatant of cultural liquid by modified Folch mixture. 2 mL of surfactant solutions, antifungal drugs (nystatin, fluconazole) or tea tree essential oil of the same concentration (5–640 μg/mL) were added to test tubes with silicone tubes (with pre-formed biofilm from test culture). To study the synergistic effect of the biofilms destruction, a mixture of surfactant solutions and antifungal substances (or essential oil) of the same concentration in a ratio of 1:1 (1 mL of each solution) was added to the test tubes. Sterile tap water (2 mL) was added to control test tubes instead of surfactants preparations, antifungal substances or essential oil. The degree of biofilm destruction (%) was determined as the difference between the adhesion of cells on the inner side of silicone tubes, untreated and treated with surfactants, antifungal drugs, essential oil, or their mixture. Results. It was found that surfactants synthesized by N. vaccinii IMV B-7405 on all substrates showed synergism of yeast and bacterial biofilms destruction on silicone tubes in a mixture with nystatin, fluconazole and tea essential oil in the whole range of investigated concentrations (5–640 μg/mL), but the highest effect was achieved at a concentration of 20–40 μg/mL. Thus, the degree of Candida albicans D-6, Candida utilis BVS-65 and Candida tropicalis PE-2 biofilms destruction under the action of a mixture of surfactants synthesized on waste from the biodiesel production and waste oil, with antifungal drugs was 45.8–71.8% and was higher than with only surfactants (21.2–41.6%), nystatin (22.4–24.1%) or fluconazole (28.1–31.3%). The destruction of Candida genus yeast biofilms under the action of surfactants synthesized on oil-containing substrates in a mixture with both nystatin and fluconazole reached 50.1–71.2%, which is 10–30% higher compared to the use of surfactants alone or only antifungal agents. The degree of Pseudomonas sp. MI-2, Escherichia coli IEM-1, Staphylococcus aureus BMS-1, Bacillus subtilis BT-2 (spores) biofilms destruction on silicone tubes treated with a mixture of tea tree essential oil and surfactants synthesized on all oil-containing substrates was 10–29% higher than in the case of using only solutions of surfactants (11.5–45.4%) or essential oil (21.4–34.5%) for the tubes treatment. Conclusions. The data obtained make it possible to consider surfactants synthesized by N. vaccinii IMV B-7405 on a wide range of cheap and accessible substrates as promising components of “antibacterial” and “antifungal” locks in combination with essential oils and antifungal agents.

Keywords: Nocardia vaccinii IMV B-7405, surfactants, antifungal drugs, tea tree essential oil, synergism of biofilm destruction.

Full text (PDF, in English)

  1. Akaraborworn O. A review in emergency central venous catheterization. Chin J Traumatol. 2017; 20(3):137–40. https://doi.org/10.1016/j.cjtee.2017.03.003
  2. Abbasi SH, Aftab RA, Chua SS. Risk factors associated with nosocomial infections among end stage renal disease patients undergoing hemodialysis: A systematic review. PLoS One. 2020; 15(6):e0234376. https://doi.org/10.1371/journal.pone.0234376
  3. Zanwar S, Jain P, Gokarn A, Devadas SK, Punatar S, Khurana S, et al. Antibiotic lock therapy for salvage of tunneled central venous catheters with catheter colonization and catheter-related bloodstream infection. Transpl Infect Dis. 2019; 21(1):e13017. https://doi.org/10.1111/tid.13017
  4. Mandolfo S, Anesi A, Maggio M, Rognoni V, Galli F, Forneris G. High success rate in salvage of catheter-related bloodstream infections due to Staphylococcus aureus, on behalf of project group of Italian society of nephrology. J Vasc Access. 2020; 21(3):336–41. https://doi.org/10.1177/1129729819875323
  5. Aminzadeh Z, Simpson P, Athan E. Central venous catheter associated blood stream infections (CVC-BSIs) in the non-intensive care settings: Epidemiology, microbiology and outcomes. Infect Dis Health. 2019; 24(4):222–8. https://doi.org/10.1016/j.idh.2019.07.003
  6. Bekçibaşi M, Dayan S, Aslan E, Kortak MZ, Hoşoğlu S. Risk factors for central venous catheter-related bloodstream infections. Infez Med. 2019; 27(3):258–65.
  7. Tatsuno K, Ikeda M, Wakabayashi Y, Yanagimoto S, Okugawa S, Moriya K. Clinical features of bloodstream infections associated with peripheral versus central venous catheters. Infect Dis Ther. 2019; 8(3):343–52. https://doi.org/10.1007/s40121-019-00257-6
  8. Burnham JP, Rojek RP, Kollef MH. Catheter removal and outcomes of multidrug-resistant central-line-associated bloodstream infection. Medicine (Baltimore). 2018; 97(42):e12782. https://doi.org/10.1097/MD.0000000000012782
  9. Pirog TP, Nikituk LV, Shevchuk TA. [Synergism of antimicrobial activity of Nocardia vaccinii IMV B-7405 surfactants and antibiotics]. Mikrobiol Z. 2017; 79(4):30–9. Ukrainian. https://doi.org/10.15407/microbiolj79.04.030
  10. Pirog TP, Nikitiuk LV. [Synergistic action of Nocardia vaccinii IMV B-7405 surfactants and antifungal agents]. Scientific Works of NUFT. 2017; 23(1):58–65. Ukrainian. https://doi.org/10.24263/2225-2924-2017-23-4-6
  11. Pirog TP, Kliuchka LV, Kliuchka IV, Shevchuk TA, Iutynska GO. Synergism of antimicrobial and anti-adhesive activity of Nocardia vaccinii IMV B-7405 surfactants in a mixture with essential oils. Mikrobiol Z. 2020; 82(4):31–40. https://doi.org/10.15407/microbiolj82.04.031
  12. Pirog TP, Shevchuk TA, Voloshina IN, Gregirchak NN. Use of claydite-immobilized oil-oxidizing microbial cells for purification of water from oil. Appl Biochem Microbiol. 2005; 41(1):51–5. https://doi.org/10.1007/s10438-005-0010-z
  13. Kim DJ, Park JH, Chang M. Species-specific characteristics of the biofilm generated in silicone tube: an in vitro study. BMC Ophthalmol; 2018. https://doi.org/10.1186/s12886-018-0750-1
  14. Gomes M-ZV, Nitschke M. Evaluation of rhamnolipids surfactants as agents to reduce the adhesion of Staphylococcus aureus to polystyrene surfaces. Lett Appl Microbiol. 2012; 49(1):960–65.
  15. Gominet M, Compain F, Beloin C, Lebeaux D. Central venous catheters and biofilms: where do we stand in 2017? APMIS. 2017; 125(4):365–75. https://doi.org/10.1111/apm.12665
  16. Ikram S, Heikal A, Finke S, Hofgaard A, Rehman Y, Sabri AN, et al. Bacillus cereus biofilm formation on central venous catheters of hospitalised cardiac patients. Biofouling. 2019; 35(2):204–16. https://doi.org/10.1080/08927014.2019.1586889
  17. Taff HT, Marchillo K, Andes DR. Preparation of Candida albicans biofilms using an in vivo rat central venous catheter model. Bio Protoc. 2013; 3(14):e823. https://doi.org/10.21769/BioProtoc.823
  18. Reitzel RA, Rosenblatt J, Gerges BZ, Vargas-Cruz N, Raad II. Minocycline-EDTA-ethanol antimicrobial catheter lock solution is highly effective in vitro for eradication of Candida auris biofilms. Antimicrob Agents Chemother. 2020; 64(4):e02146-19. https://doi.org/10.1128/AAC.02146-19
  19. Sousa C, Teixeira P, Oliveira R. Influence of surface properties on the adhesion of Staphylococcus epidermidis to acrylic and silicone. Int J Biomater. 2009; 2009:718017. https://doi.org/10.1155/2009/718017
  20. Böhlke M, Uliano G, Barcellos FC. Hemodialysis catheter-related infection: prophylaxis, diagnosis and treatment. J Vasc Access. 2015; 16(5):347–55. https://doi.org/10.5301/jva.5000368
  21. Freire MP, Pierrotti LC, Zerati AE, Benites L, da Motta-Leal Filho JM, Ibrahim KY, et al. Role of lock therapy for long-term catheter-related infections by multidrug-resistant bacteria. Antimicrob Agents Chemother. 2018; 62(9):e00569-18. https://doi.org/10.1128/AAC.00569-18
  22. Chauhan A, Lebeaux D, Ghigo JM, Beloin C. Full and broad-spectrum in vivo eradication of catheter-associated biofilms using gentamicin-EDTA antibiotic lock therapy. Antimicrob Agents Chemother. 2012; 56(12):6310–8. https://doi.org/10.1128/AAC.01606-12
  23. Labriola L, Pochet JM. Any use for alternative lock solutions in the prevention of catheter-related blood stream infections? J Vasc Access. 2017; 18(1):34–8. https://doi.org/10.5301/jva.5000681
  24. Ahmadi MS, Lee HH, Sanchez DA, Friedman AJ, Tar MT, Davies KP, et al. Sustained nitric oxide-releasing nanoparticles induce cell death in Candida albicans yeast and hyphal cells, preventing biofilm formation in vitro and in a rodent central venous catheter model. Antimicrob Agents Chemother. 2016; 60(4):2185–94. https://doi.org/10.1128/AAC.02659-15
  25. Pirog TP, Klyuchka IV, Klyuchka LV, Shevchuk TA, Iutynska GO. [Destruction of biofilms under the action of surfactants synthesized in different cultivation conditions Nocardia vaccinii IMV B-7405]. Mikrobiol Z. 2019; 81(5):3–15. https://doi.org/10.15407/microbiolj81.05.003
  26. Cavalheiro M, Teixeira MC. Candida Biofilms: threats, challenges, and promising strategies. Front Med (Lausanne). 2018; 5:28. https://doi.org/10.3389/fmed.2018.00028
  27. Janek T, Krasowska A, Czyżnikowska Ż, Łukaszewicz M. Trehalose lipid biosurfactant reduces adhesion of microbial pathogens to polystyrene and silicone surfaces: an experimental and computational approach. Front Microbiol. 2018; 9(2441). https://doi.org/10.3389/fmicb.2018.02441
  28. Ceresa C, Rinaldi M, Fracchia L. Synergistic activity of antifungal drugs and lipopeptide AC7 against Candida albicans biofilm on silicone. AIMS Bioengineering. 2017; 4(2):318–34. https://doi.org/10.3934/bioeng.2017.2.318
  29. Jafri H, Banerjee G, Khan M, Ahmad I, Abulreesh HH, Althubiani AS. Synergistic interaction of eugenol and antimicrobial drugs in eradication of single and mixed biofilms of Candida albicans and Streptococcus mutans. AMB Express. 2020; 10(1):185. https://doi.org/10.1186/s13568-020-01123-2
  30. Jafri H, Ahmad I. Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis. J Mycol Med. 2020; 30(1):100911. https://doi.org/10.1016/j.mycmed.2019.100911
  31. Li Z, Yin H, Chen W, Jiang C, Hu J, Xue Y, et al. Synergistic effect of pseudolaric acid b with fluconazole against resistant isolates and biofilm of Candida tropicalis. Infect Drug Resist. 2020; 13:2733–43. https://doi.org/10.2147/IDR.S261299
  32. D’agostino M, Tesse N, Frippiat JP, Machouart M, Debourgogne A. Essential oils and their natural active compounds presenting antifungal properties. Molecules. 2019; 24(20):3713. https://doi.org/10.3390/molecules24203713
  33. Zhao H, Shao D, Jiang C, Shi J, Li Q, Huang Q, et al. Biological activity of lipopeptides from Bacillus. Appl Microbiol Biotechnol. 2017; 101(15):5951−60. https://doi.org/10.1007/s00253-017-8396-0
  34. Pirog TP, Nikituk LV, Antonuk SI, Shevchuk TA, Iutynska GO. [Peculiarities of Nocardia vaccinii IMV B-7405 surfactants synthesis on waste oil of different quality and their antimicrobial properties]. Mikrobiol Z. 2017; 79(2):13–22. Ukrainian. https://doi.org/10.15407/microbiolj79.02.013
  35. Pirog TP, Klyuchka LV, Shevchuk TA, Muchnyk FV. [Interrelation of chemical composition and biological properties of microbial surfactants]. Mikrobiol Z. 2019; 81(3):84–104. Ukrainian. https://doi.org/10.15407/microbiolj81.03.084
  36. Algburi A, Comito N, Kashtanov D, Dicks LMT, Chikindas ML. Control of biofilm formation: antibiotics and beyond. Appl Environ Microbiol. 2017; 83(3):e02508-16. https://doi.org/10.1128/AEM.02508-16
  37. Coelho LF, Pereira MO. Exploring new treatment strategies for Pseudomonas aeruginosa biofilm infections based on plant essential oils. In: Microbial pathogens and strategies for combating them: science, technology and education. Méndez-Vilas A, ed. Badajoz: Formatex Research Center; 2013. p. 83–9.
  38. Kifer D, Mužinić V, Klarić MŠ. Antimicrobial potency of single and combined mupirocin and monoterpenes, thymol, menthol and 1,8-cineole against Staphylococcus aureus planktonic and biofilm growth. J Antibiot (Tokyo). 2016; 69(9):689–96. https://doi.org/10.1038/ja.2016.10